NCT04200326View on ClinicalTrials.gov

Real-life First Dose Effect of Fasenra in Patients With Severe Uncontrolled Asthma

CompletedOBSERVATIONAL

Enrollment

5

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

April 9, 2020

Study Completion Date

April 9, 2020

Conditions

Severe Uncontrolled Asthma

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY